Table 1.
Demographics and clinical characteristics
| Indwelling catheter (N = 68) | CISC (N = 134) | p | |
|---|---|---|---|
| Age (years), mean ± SD | 69.5 ± 12.3 | 62.1 ± 11.8 | <0.0001 |
| Age group, n (%) | 0.0002 | ||
| <50 years | 6 (9.0) | 30 (22.4) | |
| 50–65 years | 12 (17.9) | 47 (35.1) | |
| >65 years | 49 (73.1) | 57 (42.5) | |
| BMI, mean ± SD | 27.0 ± 0.6 | 27.0 ± 0.4 | 0.97 |
| White ethnicity, n (%) | 62 (92.5) | 130 (97.0) | 0.14 |
| Current smoker, n (%) | 5 (7.5) | 5 (3.7) | 0.48 |
| Gravity, median (range) | 3 (2–4) | 3 (2–4) | 0.77 |
| Parity, median (range) | 3 (2–3) | 2 (2–3) | 0.24 |
| Diabetes, n (%) | 13 (19.4) | 11 (8.2) | 0.021 |
| Anxiety, n (%) | 10 (14.9) | 13 (9.7) | 0.27 |
| Arthritis, n (%) | 22 (32.8) | 32 (23.9) | 0.18 |
| Neurologic condition, n (%)a | 6 (9.0) | 10 (7.5) | 0.71 |
| History of incontinence, n (%) | 34 (50.7) | 90 (67.2) | 0.024 |
| Prior hysterectomy, n (%) | 31 (46.3) | 55 (41.0) | 0.48 |
| Prior prolapse surgery, n (%) | 13 (19.4) | 26 (19.4) | 1.00 |
| Prior incontinence surgery, n (%) | 4 (6.0) | 19 (14.2) | 0.10 |
| Pre-operative anticholinergic use, n (%) | 7 (10.5) | 16 (11.9) | 0.75 |
| Pre-operative POP-Q stage, n (%) | 0.26 | ||
| II | 13/59 (22.0) | 26/95 (27.4) | |
| III | 39/59 (66.1) | 51/95 (56.7) | |
| IV | 7/59 (11.9) | 11/95 (11.6) | |
| Pre-operative counseling appointment, n (%) | 27 (40.3) | 48 (35.8) | 0.54 |
| Pre-operative PVR (mL), mean ± SD | 91.7 ± 113.6 | 89.9 ± 97.2 | 0.90 |
| Pre-operative CISC teaching, n (%) | 1 (1.5) | 3 (2.2) | 0.72 |
| Ever performed CISC, n (%) | 0 (0.0) | 6 (4.5) | 0.18 |
BMI body mass index, CISC clean intermittent self-catheterization, PVR post-void residual
a
Neurologic conditions include Parkinson’s disease, multiple sclerosis, history of stroke